A post-pandemic boom made lab space the hero of commercial real estate, an antidote to the pandemic slump and a magnet for investor cash. But the life sciences sector is losing its shine fast, with ...

We used to say data is the new oil. In commercial life sciences, context has become oxygen. AI can read millions of pages, extract structure from chaos and turn scattered trial data, clinical notes ...

Over the past four years, private equity (PE) firms that invested in life science assets have faced a difficult reality. While many investors still debate whether some sectors of the market are in a ...

The life sciences sector remains a critical area of focus for the US Securities and Exchange Commission (SEC) under the current administration. Companies operating in the healthcare, pharmaceutical, ...